Med Business World

Your source for healthcare business

Latest on Med Business World

Mansathali Intervenes to Rescue Child from Social Media Addiction

Today, the whole world is dominated by digital technology; it doesn’t matter what your age or gender is, you are tech addicted. Concerns about the impact of social media addiction on children’s well-being have become more pressing than ever. However,…

Groundbreaking Study by Dr. Agarwal’s Eye Hospital on post-crosslinking surgery patients Wins ‘Best Scientific Poster Award’ at ASCRS 2024 Annual Meeting

Dr Agarwal’s Eye Hospital recently announced that their accomplished research team have been honoured with the prestigious ‘Best Scientific Poster Award’ at the 2024 Annual Meeting of the American Society for Cataract and Refractive Surgery (ASCRS). This recognition comes in…

Acryno To Blends AI and Luxury Concierge Services to Reimagine Healthcare

In an era of rising health costs, increased time to access providers, and growing frustration, it can be difficult for the average person to get the care they need. For those with chronic conditions, these challenges are multiplied exponentially. Acryno…

Clarius and ThinkSono Introduce a New AI-Guided Ultrasound System Enabling Rapid Assessments of DVTs

Clarius Mobile Health, a leading provider of high-definition handheld ultrasound systems, and ThinkSono, a pioneering medical technology company specializing in ultrasound artificial intelligence (AI) guidance solutions, are introducing a new AI-guided ultrasound system in Europe, which will improve the efficiency…

Abbisko Completed All Patient Enrollment for The Global Phase III TGCT Trial of Its CSF-1R Inhibitor – Pimicotinib

9 April 2024 (Beijing Time), Abbisko Therapeutics Co., Ltd. (Abbisko Therapeutics) announced the completion of patient enrollment for its pivotal Phase III trial, MANEUVER (ABSK021-301) STUDY, for evaluating the efficacy and safety of pimicotinib in patients with tenosynovial giant cell tumor (TGCT)….

Transcenta Announces Collaboration with Agilent to Develop a Claudin18.2 Companion Diagnostic to Support Osemitamab (TST001) Global Phase III Trial

Transcenta Holding Limited (“Transcenta”) (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, and Agilent Technologies, announce a collaboration to develop a Claudin18.2 (CLDN18.2) companion diagnostic to support TranStar301 global…

Health Carousel Nurse Honored with CGFNS DAISY Award for Outstanding International Nurse Recruiter

Health Carousel is proud to announce that our very own Nurse Manager, Christy Craft, has been honored with the prestigious CGFNS DAISY Award for Outstanding International Nurse Recruiter. This award, presented by the Commission on Graduates of Foreign Nursing Schools (CGFNS) International,…

FDA-Approved CoolSculpting is a Safe & Effective Solution for those Seeking Permanent Fat Reduction: Says Expert

FDA-approved solutions are at the forefront of modern cosmetic procedures, offering safe and effective alternatives to traditional methods. One such solution rapidly gaining popularity is CoolSculpting, a revolutionary fat-freezing treatment that promises a slimmer, more sculpted figure without the need…

FDA Grants HemoSonics Expanded Use of its Critical Bleeding Management System with Special 510(k) Clearance

HemoSonics, a medical device company focused on acute bleeding management, today announced it has received Special 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the expanded use of arterial blood samples with its Quantra QStat® Cartridge. HemoSonics’…

Neurocrine Biosciences Announces First-Patient Dosed in Phase 2 Clinical Study Evaluating NBI-1070770 in Adults with Major Depressive Disorder

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the first patient has been randomized for its Phase 2 clinical study to evaluate the efficacy, safety, and tolerability of investigational compound NBI-1070770 in adults with major depressive disorder. NBI-1070770 is a novel,…